---
title: "Zhitong A-share lock-up release overview | February 17"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/228484821.md"
description: "On February 17th, 19 listed companies will have their restricted shares unlocked, with a total market value of approximately 6.288 billion yuan. The unlocking situation includes several companies such as LZLJ, JINLING PHARM., and GUANGJI PHARMA, involving types such as equity incentives and the allocation of additional A shares to original shareholders. The specific number of unlocked shares ranges from 37,100 to 219 million"
datetime: "2025-02-17T01:01:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/228484821.md)
  - [en](https://longbridge.com/en/news/228484821.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/228484821.md)
generator: "portal-rs"
---

# Zhitong A-share lock-up release overview | February 17

According to the Zhitong Finance APP, on February 17th, a total of 19 listed companies had their restricted shares unlocked, with a total market value of approximately 6.288 billion yuan.

The specific situation of the restricted share unlock today is as follows:

| Stock Abbreviation | Stock Code | Restricted Share Type                                      | Unlocked Shares |
| ------------------ | ---------- | ---------------------------------------------------------- | --------------- |
| LZLJ               | 000568     | Equity Incentive Restricted Circulation                    | 37,100          |
| JINLING PHARM.     | 000919     | Equity Incentive Restricted Circulation                    | 1,920,000       |
| GUANGJI PHARMA     | 000952     | Equity Incentive Restricted Circulation                    | 2,520,900       |
| Jiangsu Wuzhong    | 600200     | Equity Incentive Restricted Circulation                    | 961,200         |
| China Software     | 600536     | Equity Incentive Restricted Circulation                    | 57,200          |
| Xinhua Medical     | 600587     | Equity Incentive Restricted Circulation                    | 1,784,600       |
| Baoxin Software    | 600845     | Equity Incentive Restricted Circulation                    | 10,257,800      |
| Hangzhou Oxygen    | 002430     | Equity Incentive Restricted Circulation                    | 5,213,100       |
| Anhui Natural Gas  | 603689     | Equity Incentive Restricted Circulation                    | 2,506,400       |
| Tongda Electric    | 603390     | Equity Incentive Restricted Circulation                    | 772,700         |
| Dashengda          | 603687     | Additional A-share Original Shareholder Allocation Listing | 3,529,400       |
| Huaxiang Co., Ltd. | 603112     | Equity Incentive Restricted Circulation                    | 336,700         |
| HeFu China         | 603122     | Pre-issue Share Restricted Circulation                     | 219,000,000     |
| Yuehai Feed        | 001313     | Pre-issue Share Restricted Circulation                     | 481,000,000     |
| Zhilifang          | 301312     | Equity Incentive Restricted Circulation                    | 333,900         |
| Zhongchumei        | 688267     |                                                            | 4,396,000       |
| Zhongrun Optics    | 688307     |                                                            | 1,100,000       |
| Xinyu Ren          | 688573     |                                                            | 273,800         |
| Sinan Navigation   | 688592     |                                                            | 1,118,700       |

### Related Stocks

- [000952.CN](https://longbridge.com/en/quote/000952.CN.md)
- [000919.CN](https://longbridge.com/en/quote/000919.CN.md)
- [000568.CN](https://longbridge.com/en/quote/000568.CN.md)
- [002430.CN](https://longbridge.com/en/quote/002430.CN.md)
- [600536.CN](https://longbridge.com/en/quote/600536.CN.md)
- [603687.CN](https://longbridge.com/en/quote/603687.CN.md)
- [600587.CN](https://longbridge.com/en/quote/600587.CN.md)
- [603689.CN](https://longbridge.com/en/quote/603689.CN.md)
- [688267.CN](https://longbridge.com/en/quote/688267.CN.md)

## Related News & Research

- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)
- [Brave’s browser one-ups Chrome with its new support for email aliases](https://longbridge.com/en/news/297361090.md)
- [My Mountain Mover Recognized Among the 2026 Inc. 5000 Fastest-Growing U.S. Companies](https://longbridge.com/en/news/297087696.md)
- [You Should Feel Good About The Flock Debate](https://longbridge.com/en/news/297408360.md)
- [Qubic: Ant Colony Mining goes live - 29 Aug 2026](https://longbridge.com/en/news/297406892.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**